DONSON expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.283400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.687600E-01
Normal-vs-Stage2
5.864400E-01
Normal-vs-Stage3
9.038000E-01
Normal-vs-Stage4
9.481000E-01
Stage1-vs-Stage2
7.634200E-01
Stage1-vs-Stage3
5.011600E-01
Stage1-vs-Stage4
4.902400E-01
Stage2-vs-Stage3
4.352000E-01
Stage2-vs-Stage4
5.050200E-01
Stage3-vs-Stage4
9.151600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.120800E-01
Normal-vs-AfricanAmerican
6.036400E-01
Normal-vs-Asian
8.184800E-01
Caucasian-vs-AfricanAmerican
9.170400E-01
Caucasian-vs-Asian
6.435200E-01
AfricanAmerican-vs-Asian
8.374800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.111600E-01
Normal-vs-Female
6.507400E-01
Male-vs-Female
7.472600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.773400E-01
Normal-vs-Age(41-60Yrs)
2.918400E-01
Normal-vs-Age(61-80Yrs)
7.859600E-01
Normal-vs-Age(81-100Yrs)
8.233800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.55829999995516E-06
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.542800E-03
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.913590E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.280200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.550240E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.493600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.584600E-01
Normal-vs-Daily Drinker
8.439400E-01
Normal-vs-Weekly Drinker
3.257000E-01
Normal-vs-Occasional Drinker
6.797200E-01
Normal-vs-Social Drinker
4.846800E-01
Non Drinker-vs-Daily Drinker
1.741370E-01
Non Drinker-vs-Weekly Drinker
2.726200E-01
Non Drinker-vs-Occasional Drinker
6.455400E-01
Non Drinker-vs-Social Drinker
7.709400E-01
Daily Drinker-vs-Weekly Drinker
2.036000E-02
Daily Drinker-vs-Occasional Drinker
2.734200E-01
Daily Drinker-vs-Social Drinker
9.750000E-02
Weekly Drinker-vs-Occasional Drinker
1.450560E-01
Weekly Drinker-vs-Social Drinker
4.283000E-01
Occasional Drinker-vs-Social Drinker
4.360000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.638800E-01
Normal-vs-Grade 2
9.818800E-01
Normal-vs-Grade 3
9.934600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.300120E-02
Grade 1-vs-Grade 3
1.410080E-02
Grade 1-vs-Grade 4
8.638800E-01
Grade 2-vs-Grade 3
5.784000E-01
Grade 2-vs-Grade 4
9.818800E-01
Grade 3-vs-Grade 4
9.934600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.435400E-01
Normal-vs-NonDiabetic
6.101200E-01
Diabetic-vs-NonDiabetic
1.931030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.547800E-01
Normal-vs-NoPancreatitis
7.974000E-01
Pancreatitis-vs-NoPancreatitis
2.026200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.498800E-01
Normal-vs-N1
6.424200E-01
N0-vs-N1
5.947000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.275600E-01
Normal-vs-TP53-NonMutant
6.182800E-01
TP53-Mutant-vs-TP53-NonMutant
1.007760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
